(MENAFN- Ameliorate Solutions)
Global Point-of-Care Molecular Diagnostics Market This market research provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Research classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
Market Overview-
Point-of-Care (POC) Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help prescribe treatment in the first instance without having to wait for the final results. In past decades, the prevalence of infectious diseases and chronic illnesses like cancer have increased. This has led to an increase in demand for novel diagnostic methods, which has led to progress in technological advancements and pharmacogenomics. This has also increased the demand for POC testing. These factors have helped the growth of the POC molecular testing market.
However, uncertain reimbursement scenarios have dissuaded many manufacturers to enter the market. Also, the lack of high-complexity test centers to use POC molecular testing have also hindered the market growth.
Avail a Sample Copy before Purchase:
https://www.marketinsightsreports.com/reports/01091744859/point-of-care-molecular-diagnostics-market-growth-trends-and-forecast-2020-2025/inquiry?source=MW & Mode=21
Market competition by Top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the Top players including-
Abbott Laboratories, Bayer Healthcare, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Danaher Corporation, BioMerieux, Dako, Abaxis Inc., OraSure Technologies Inc., Qiagen
Market segment by Regions/Countries, this report covers
North America (U.S., Canada, Mexico)
Global (Germany, UK, France, Rest of Global)
Asia Pacific (China, India, Japan, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East & Africa
Key Market Trends
Application in Oncology is Expected to Register a High CAGR
Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 17 million new cancer cases worldwide in 2018.
Many current point-of-care (POC) diagnostics utilize lateral flow immunoassay based technologies. Lateral flow immunoassays are devices that incorporate antibodies to detect the presence of an analyte like cancer biomarkers. In principle, a lateral flow test is a device that will provide a qualitative answer to the presence of a biomarker in a short period of time. Hence, the demand for these quick detection tests is expected to increase as the incidence of cancer increases.
North America is Expected to Dominate the Market
The prevalence of cancer in the United States is one of the highest in North American countries like the United States (US) and Mexico. According to a 2018 report by the National Cancer Institute, the incidence of cancer in the US is 439.2 per 100,000 men and women per year. The prevalence of the infectious disease is also high in the United States and Mexico. This has created a high demand for point-of-care diagnostics tests.
However, the United States has a developed and well-structured health care system. The system also encourages research and development. These policies encourage global players to enter the US, and eventually the North American market. As a result, this region enjoys the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.
Get Exclusive Discount at-
https://www.marketinsightsreports.com/reports/01091744859/point-of-care-molecular-diagnostics-market-growth-trends-and-forecast-2020-2025/discount?source=MW & Mode=21
Major points covered in this research are:-
─Point-of-Care Molecular Diagnostics Market Overview, Segment by Type (Product Category), by Application, by Region (2020-2025), Competition by Manufacturers
─Global Market Size (Value) of Point-of-Care Molecular Diagnostics (2020-2025)
─Global Point-of-Care Molecular Diagnostics Capacity, Production, Revenue (Value), Supply (Production), Consumption, Export, Import by Region (2020-2025)
─Global Point-of-Care Molecular Diagnostics Production, Revenue (Value), Price Trend by Type
─Global Point-of-Care Molecular Diagnostics Market Analysis by Application
─Global Point-of-Care Molecular Diagnostics Manufacturers Profiles/Analysis
─Point-of-Care Molecular Diagnostics Manufacturing Cost Analysis
─Industrial Chain, Sourcing Strategy and Downstream Buyers
─Marketing Strategy Analysis, Distributors/Traders
─Market Effect Factors Analysis
─Global Point-of-Care Molecular Diagnostics Market Forecast (2020-2025)
─Competitive Landscape
─Research Findings and Conclusion
Finally, this Point-of-Care Molecular Diagnostics report covers the market scenario and its development prospects over the coming years. Report likewise manages the type analysis, contrasting it with the significant application, recent Point-of-Care Molecular Diagnostics product development and gives an outline of the potential Global market.
Contact US:
Irfan Tamboli (Sales)
Phone: + 1704 266 3234
Mob: +91-750-707-8687
MENAFN18012020007010643ID1099570078
-MENAFN18012020007010643ID1099570078-->
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.